尿酸クリアランス
WordNet
- permission to proceed; "the plane was given clearance to land"
- the distance by which one thing clears another; the space between them
- street name for lysergic acid diethylamide (同)back breaker, battery-acid, dose, dot, Elvis, loony toons, Lucy in the sky with diamonds, pane, superman, window pane, Zen
- any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt
- having the characteristics of an acid; "an acid reaction"
- in or relating to or obtained from urine; "uric acid"
PrepTutorEJDIC
- 〈U〉〈C〉(…の)取り片付け,除去,掃除《+『of』+『名』》 / 〈U〉〈C〉(積荷の)通関手続き,(船の)出港免状 / (またclearance sale)〈C〉大棚ざらいの売出し / 〈U〉〈C〉(手形の)決済,(小切手の)現金化 / 〈U〉〈C〉(二つの物の間の)あき,余裕;(特に)道路面・川の面から橋げたまでの高さ / 〈U〉〈C〉秘密情報の使用許可;(秘密情報を扱う人の)信頼性調査;公安調査
- 酸性の / 酸味のある,すっぱい(sour) / (言葉・態度などが)厳しい,しんらつな / 酸 / すっぱいもの / 《俗》=LSD
- 尿の,尿に関する(含まれている),尿から得られる
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 尿酸腎結石症uric acid nephrolithiasis [show details]
…urine (ie, less gastrointestinal clearance of the daily uric acid load in favor or more urinary clearance) . These patients may have a persistent increase in uric acid stone formation in contrast to the …
- 2. 尿酸による腎疾患uric acid renal diseases [show details]
… UAN may show many uric acid crystals , but can be unremarkable due to no output from the obstructed nephrons. Overexcretion of uric acid can be documented in many patients by a uric acid-to-creatinine ratio …
- 3. 尿酸の産生と排泄のバランスurate balance [show details]
…still relatively reduced) uric acid clearance at the kidney. This view was supported by the finding that patients with two risk alleles showed higher serum urate and urinary uric acid levels, implying that …
- 4. 低尿酸血症:原因および臨床的意義hypouricemia causes and clinical significance [show details]
… elimination from the intestine to the urine (ie, less gastrointestinal clearance of the daily uric acid load in favor of more urinary clearance) . How this might occur is not known. In addition, some of these …
- 5. 無症候性高尿酸血症asymptomatic hyperuricemia [show details]
…exceed those in women of reproductive age due to enhancement of renal uric acid clearance by estrogenic compounds. Thus, uric acid variation during the menstrual cycle indicates an inhibitory influence …
English Journal
- Sildenafil obviates ischemia-reperfusion injury-induced acute kidney injury through peroxisome proliferator-activated receptor γ agonism in rats.
- Mohey V1, Singh M1, Puri N1, Kaur T2, Pathak D3, Singh AP4.
- The Journal of surgical research.J Surg Res.2016 Mar;201(1):69-75. doi: 10.1016/j.jss.2015.09.035. Epub 2015 Oct 20.
- BACKGROUND: Sildenafil is a phosphodiesterase inhibitor used clinically for treating erectile dysfunction. Few studies suggest sildenafil to be a renoprotective agent. The present study investigated the involvement of peroxisome proliferator-activated receptor γ (PPAR-γ) in sildenafil-mediated pro
- PMID 26850186
- Nephro-protective potential of Morus alba, a prospective experimental study on animal models.
- Ullah N1, Khan MA2, Khan S1, Ahmad H3, Asif AH4, Khan T5.
- Pharmaceutical biology.Pharm Biol.2016 Mar;54(3):530-5. doi: 10.3109/13880209.2015.1052149. Epub 2015 Jun 11.
- CONTEXT: Morus alba L. (Moraceae) is traditionally used for the treatment of urinary incontinency due its strong diuretic properties.OBJECTIVE: The present study explores the renal protective effects of M. alba, due to its free radical scavenging properties, in order to provide experimental evidence
- PMID 26067678
- Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 Diabetes.
- Lytvyn Y1, Mahmud FH2, Daneman D2, Deda L2, Dunger DB3, Deanfield J4, Dalton RN5, Elia Y2, Har R6, Bradley TJ7, Slorach C7, Hui W7, Moineddin R8, Reich HN6, Scholey JW6, Mertens L7, Sochett E2, Cherney DZ9.
- Diabetes care.Diabetes Care.2016 Feb 19. pii: dc152345. [Epub ahead of print]
- OBJECTIVE: The relationship between plasma uric acid (PUA) and renal and cardiovascular parameters in adolescents with type 1 diabetes (T1D) is not well understood. Our aims in this exploratory analysis were to study the association between PUA and estimated glomerular filtration rate (eGFR), urinar
- PMID 26895883
Japanese Journal
- 胎盤における免疫毒性:妊娠異常におけるインフラマソームの役割
- 白砂 孔明
- 日本毒性学会学術年会 47.1(0), S16-3, 2020
- <p>次世代を残すための様々な妊娠機構に対して免疫応答が関与する。例えば、マクロファージが卵巣機能を調節して着床・妊娠を維持する、半異物である胎児の許容には制御性T細胞が重要であるなど、その働きは多岐に渡る。一方、免疫機構の破綻や過剰な炎症性サイトカイン産生等によって着床障害、流・早産、妊娠高血圧腎症(preeclampsia、PE)等が起きる。多くの異常妊娠では病原体等の感染は関与し …
- NAID 130007898497
- <b>腎症合併高血圧においてシルニジピンが血清尿酸値を減少させる要件</b>
- 斉田 光彦
- 痛風と核酸代謝 42(1), 41-50, 2018
- <p><i>背景</i>:高血圧や慢性腎臓病(CKD)ではレニン・アンジオテンシン(RA)系及び交感神経系の活性化によりナトリウム(Na)と尿酸の尿中排泄が減少することから,高尿酸血症を合併していることが多い.降圧薬として用いられるシルニジピン(CIL)は他のカルシウム拮抗薬(CCB)と異なり,交感神経系に抑制的に働く事や尿酸生成を阻害する事などが報告されている …
- NAID 130007419506
- Effects of Irbesartan on Uric Acid Metabolism in Patients with Treated Essential Hypertension
- Miyazaki Satoshi,Kuwabara Masanari,Sakaguchi Hiromi,Nozaka Yoshihito,Kishida Senzou,Ogino Kazuhide,Kato Masahiko,Taniguchi Shin-ichi,Yoshida Akio,Ninomiya Haruaki,Yamamoto Kazuhiro,Sakuragi Tetsushi,Hisatome Ichiro,Hamada Toshihiro,Sugihara Shinobu,Park Daeho,Inoue Kazuoki,Mizuta Einosuke,Yamamoto Yasutaka,Ohtahara Akira
- Vascular Failure 2(1), 11-19, 2018
- … <p><b>Background: </b>Irbesartan has been reported to inhibit renal uric acid reabsorption and thereby decrease serum uric acid (Sur) levels. … However, its effect on uric acid metabolism in hypertensive patients has not been reported. …
- NAID 130007399343
Related Links
- Uric acid profile is given in Table 3. It shows significant differences between the control and patient groups with respect to their serum uric acid levels (p=0.05), even though the mean levels are within the normal ranges. Daily urinary uric ...
- 1. Isr J Med Sci. 1988 Jan;24(1):20-3. Increased uric acid clearance in the syndrome of inappropriate secretion of antidiuretic hormone. Sonnenblick M, Rosin A. Department of Geriatrics, Shaare Zedek Medical Center, Jerusalem ...
★リンクテーブル★
[★]
- 英
- uric acid clearance, CUA
- 関
- 尿中尿酸
検査項目
|
基準値
|
排泄低下型
|
産生過剰型
|
尿中尿酸排泄量(mg/kg/h)
|
0.48~0.51
|
0.47以下
|
0.52以上
|
尿酸クリアランス(mL/min)
|
6.2~12.6
|
6.1以下
|
6.2以上
|
尿酸クリアランスクレアチニンクリアランス比(%)
|
5.5~11.1
|
5.4以下
|
-
|
尿中尿酸/クレアチニン比
|
-
|
0.4以下
|
0.8以上
|
- 基準範囲:6.2~12.6ml/分
- 判定 :排泄低下・・・CUA<6.2
[★]
パラアミノ馬尿酸クリアランス
[★]
- 関
- urate、uric acid
[★]
クリアランス